Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline
Adam P. Bress, Lisandro D. Colantonio, Richard Cooper, et al.
Circulation (2018) Vol. 139, Iss. 1, pp. 24-36
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Heart Disease and Stroke Statistics—2021 Update
Salim S. Virani, Álvaro Alonso, Hugo J. Aparicio, et al.
Circulation (2021) Vol. 143, Iss. 8
Open Access | Times Cited: 4741
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2022) Vol. 145, Iss. 8
Open Access | Times Cited: 4301
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2023) Vol. 147, Iss. 8
Open Access | Times Cited: 4252
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 934
Roles and mechanisms of exosomal non-coding RNAs in human health and diseases
Chen Li, Yu‐Qing Ni, Hui Xu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 273
Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group
Holly C. Gooding, Samuel S. Gidding, Andrew E. Moran, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 19
Open Access | Times Cited: 131
Guideline-Driven Management of Hypertension
Robert M. Carey, Jackson T. Wright, Sandra J. Taler, et al.
Circulation Research (2021) Vol. 128, Iss. 7, pp. 827-846
Open Access | Times Cited: 99
2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
Donald E. Casey, Randal J. Thomas, Vivek Bhalla, et al.
Circulation Cardiovascular Quality and Outcomes (2019) Vol. 12, Iss. 11
Open Access | Times Cited: 92
Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat
Martin Bødtker Mortensen, Børge G. Nordestgaard
JAMA Cardiology (2019) Vol. 4, Iss. 11, pp. 1131-1131
Open Access | Times Cited: 61
Hypertension and race/ethnicity
Bradley Deere, Keith C. Ferdinand
Current Opinion in Cardiology (2020) Vol. 35, Iss. 4, pp. 342-350
Closed Access | Times Cited: 61
The Burden of Resistant Hypertension Across the World
Luísa Campos Caldeira Brant, Luiz Guilherme Passaglia, Marcelo Martins Pinto Filho, et al.
Current Hypertension Reports (2022) Vol. 24, Iss. 3, pp. 55-66
Closed Access | Times Cited: 35
2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure
Donald E. Casey, Randal J. Thomas, Vivek Bhalla, et al.
Journal of the American College of Cardiology (2019) Vol. 74, Iss. 21, pp. 2661-2706
Open Access | Times Cited: 46
The Potential of Natural Products in the Management of Cardiovascular Disease
Harshita Singhai, Sunny Rathee, Sanjay Jain, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 8, pp. 624-638
Closed Access | Times Cited: 6
Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States
Kathryn Foti, Dan Wang, Alex R. Chang, et al.
Kidney International (2021) Vol. 99, Iss. 3, pp. 686-695
Open Access | Times Cited: 28
Age and sex disparities in blood pressure control and therapeutic inertia: Impact of a quality improvement program
Olivia Myers, Talar Markossian, Beatrice D. Probst, et al.
American Journal of Preventive Cardiology (2024) Vol. 17, pp. 100632-100632
Open Access | Times Cited: 4
Accurate Risk Factors of Cardiotoxicity in Patients With NSCLC Treated With Osimertinib
Lei Wu, Ning Liu, Meili Sun
Journal of Thoracic Oncology (2025) Vol. 20, Iss. 3, pp. e44-e45
Closed Access
Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong
Robert M. Carey, Paul K. Whelton
Hypertension (2020) Vol. 76, Iss. 5, pp. 1384-1390
Open Access | Times Cited: 25
Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study
Sadaf G Sepanlou, Farid Najafi, Hossein Poustchi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018
Fanghua Li, Anbang Sun, Feng Wu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Stage 1 hypertension by the 2017 American College of Cardiology/American Heart Association hypertension guidelines and risk of cardiovascular disease events: systematic review, meta-analysis, and estimation of population etiologic fraction of prospective cohort studies
Minghui Han, Qing Chen, Leilei Liu, et al.
Journal of Hypertension (2019) Vol. 38, Iss. 4, pp. 573-578
Closed Access | Times Cited: 20
Characteristics of Populations Excluded From Clinical Trials Supporting Intensive Blood Pressure Control Guidelines
Timothy S. Anderson, Michelle C. Odden, Joanne Penko, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 7
Open Access | Times Cited: 17
Prognosis of Systolic Pressure 130 to 139 According to Risk. A Prospective Cohort Study Between 1992 and 2019
J.A. Divisón, Julio A. Carbayo Herencia, Marta Simarro-Rueda, et al.
Hypertension (2023) Vol. 80, Iss. 11, pp. 2485-2493
Closed Access | Times Cited: 6
Evolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective
Paul K. Whelton
Canadian Journal of Cardiology (2019) Vol. 35, Iss. 5, pp. 570-581
Open Access | Times Cited: 17
Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension
Aisha T. Langford, Oluwasegun P. Akinyelure, Tony Moore, et al.
Hypertension (2020) Vol. 76, Iss. 5, pp. 1600-1607
Open Access | Times Cited: 15
Hypertension Guidelines: Effect of Blood Pressure Targets
Rhian M. Touyz
Canadian Journal of Cardiology (2019) Vol. 35, Iss. 5, pp. 564-569
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top